Interstitial fluid flow in and around the tumor tissue is a physiologically relevant mechanical signal that regulates intracellular signaling pathways throughout the tumor. Yet, the effects of interstitial flow and associated fluid shear stress on the tumor cell function have been largely overlooked. Using in vitro bioengineering models in conjunction with molecular cell biology tools, we found that fluid shear (2 dyn/cm 2 ) markedly upregulates matrix metalloproteinase 12 (MMP-12) expression and its activity in human chondrosarcoma cells. MMP-12 expression is induced in human chondrocytes during malignant transformation. However, the signaling pathway regulating MMP-12 expression and its potential role in human chondrosarcoma cell invasion and metastasis have yet to be delineated. We discovered that fluid shear stress induces the synthesis of insulin growth factor-2 (IGF-2) and vascular endothelial growth factor (VEGF) B and D, which in turn transactivate MMP-12 via PI3-K, p38 and JNK signaling pathways. IGF-2-, VEGF-B-or VEGF-D-stimulated chondrosarcoma cells display markedly higher migratory and invasive potentials in vitro, which are blocked by inhibiting MMP-12, PI3-K, p38 or JNK activity. Moreover, recombinant human MMP-12 or MMP-12 overexpression can potentiate chondrosarcoma cell invasion in vitro and the lung colonization in vivo. By reconstructing and delineating the signaling pathway regulating MMP-12 activation, potential therapeutic strategies that interfere with chondrosarcoma cell invasion may be identified.
INTRODUCTION
Chondrosarcoma is a malignant bone tumor of chondrogenic origin. Interstitial fluid flow is a relevant mechanical signal in cartilage and bone (patho)physiology. 1, 2 Interstitial fluid flow in and around the normal or tumor tissue alters the local mechanical microenvironment and regulates intracellular signaling pathways. Jain and Chary 3 have reported that interstitial fluid velocities in tumors vary between 0.1 and 2 μm/s, corresponding to fluid shear stresses of up to~1 dyn/cm 2 . 4 Others have measured fluid flow velocities in tumors of up to 4 μm/s. 5 To date, the effects of interstitial flow and associated fluid shear on chondrosarcoma cell function have been largely overlooked.
Chondrosarcomas have the capacity to invade locally and generate metastases with a predilection for the lungs. 6 Low or intermediate grade (I or II) chondrosarcoma have indolent growth and low metastatic potential, whereas grade III lesions exhibit high metastatic potential. Chondrosarcoma cell invasion into normal tissue is facilitated by the degradation of the extracellular matrix (ECM) within and around the tumor. The ECM of chondrosarcomas is comprised primarily of fibrillar collagens. Collagen types II and X correspond to a differentiated cell phenotype associated with good prognosis, whereas collagen type I is associated with a more proliferative, dedifferentiated phenotype and poorer clinical prognosis. 7 Collagen degradation is mediated by the action of matrix metalloproteinases (MMPs), which comprise a multigene family with over 22 members. MMP-1, MMP-2, MMP-3, MMP-9 and MMP-13 are expressed in human chondrosarcoma cells. 8 MMP-1 is the best-studied metalloproteinase in chondrosarcoma; it is upregulated in locally invasive tumors and its expression correlates with chondrosarcoma recurrence. 9 It has also been reported that MMP-12 expression is induced in human chondrocytes during the malignant transformation. 10 Yet, little is known regarding the potential contribution of MMP-12 to chondrosarcoma cell invasion.
MMP-12 is upregulated in human SW1353 chondrosarcoma cells upon treatment with growth factors or cytokines, such as transforming growth factor β or tumor necrosis factor α. 10 Enhanced expression of MMP-12 is associated with glioma and endometrial adenocarcinoma cell invasion. 11, 12 More importantly, MMP-12 correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. 13 In contrast, MMP-12 expression by the carcinoma cells is associated with increased survival of colon cancer patients. 14 In line with this outcome, Houghton et al. 15 also reported that MMP-12 knock in suppresses lung metastasis of Lewis lung carcinoma and B16-F10 melanoma cells. Thus, MMP-12 exerts divergent effects on tumor metastasis that are tumor cell type specific.
In this study, we report that application of physiologically relevant fluid shear stress (2 dyn/cm 2 ) markedly upregulates MMP-12 expression and its activity in human chondrosarcoma cells. We also delineated the signaling mechanism by which fluid shear activates MMP-12 and its effects on chondrosarcoma cell migration and invasion in vitro. Because chondrosarcoma display a predilection for metastasis to the lungs, we investigated the effects of recombinant human (rh)MMP-12 on the lung colonization in vivo using a tail vein injection model.
RESULTS

MMP-12 is markedly upregulated in human chondrosarcoma tissues and shear-activated chondrosarcoma cells
In light of prior data, suggesting that MMP-12 expression is induced in human chondrocytes during the fetal development and malignant transformation, 10 we evaluated the expression levels of MMP-12 in human chondrosarcoma tissues relative to normal controls. As shown in Figure 1 , MMP-12 immunostaining was detected in the cytoplasm and membrane of human chondrosarcomas. Importantly, MMP-12 expression was markedly (44.5-fold) increased in human chondrosarcomas compared with normal tissues (Figure 1 ).
Fluid shear stress has been reported to influence the invasive potential of glioma cells through the modulation of MMP-1 and MMP-2, 4 which degrade the ECM within and around the tumor. We thus investigated the effects of fluid shear on the regulation of MMPs in human chondrosarcoma cells. The human SW1353 chondrosarcoma cell line was chosen as a model system because it is the most commonly used cell line for bone tumor research. 16 We also verified select data using Hs 819.T and CH2879 chondrosarcoma cells as models. Our data revealed that the messenger RNA (mRNA) expression levels of MMP-12 increased progressively with increasing shear stress, reaching a maximum at 2 dyn/cm 2 after 48 h, and returned to baseline levels at 12-20 dyn/ cm 2 ( Supplementary Table S1 ). Thus, subsequent experiments focused on analyzing cell responses after application of 2 dyn/cm 2 for 48 h. Of all known MMPs, MMP-12 displayed the highest (35-fold) increase in the mRNA expression in shear-activated (2 dyn/cm 2 for 48 h) human SW1353 chondrosarcoma cells ( Supplementary Table S2 ). Smaller, yet significant, shearmediated increases were detected in MMP-1 (eightfold) and MMP-7 (fivefold) mRNA levels ( Supplementary Table S2 ). Interestingly, exposure of SW1353 cells to a higher shear stress level (20 dyn/cm 2 for 48 h) failed to upregulate the mRNA levels of any MMP relative to static control specimens ( Supplementary Table  S2 ). Similar observations were made using Hs 819.T chondrosarcoma cells ( Supplementary Table S3 ). In addition to the regulation of mRNA levels, exposure of human chondrosarcoma cells to low (2 dyn/cm 2 ), but not high (20 dyn/cm 2 ), shear stress markedly upregulated the protein expression and enzymatic activity of MMP-12 (Figure 2a ). Collectively, these results suggest that fluid shear stress may contribute to chondrosarcoma cell invasion primarily via the induction of MMP-12.
IGF-2, VEGF-B and VEGF-D mediate the shear-dependent activation of MMP-12 in human chondrosarcoma cells Fluid shear stress (12 dyn/cm 2 ) induces G 2 /M cell cycle arrest in human chondrosarcoma SW1353 cells. 17 Along these lines, high (20 dyn/cm 2 ), but not low (2 dyn/cm 2 ), levels of fluid shear induce chondrocyte apoptosis. 18, 19 In view of these observations, we hypothesized that growth factors secreted by chondrosarcoma cells subjected to low levels of shear facilitate their survival and promote cell invasion via the upregulation of MMP-12. To test our hypothesis, we evaluated the effects of shear stress on the mRNA expression of different growth factors that have been implicated in chondrosarcoma cell invasion. Our analysis reveals that low (2 dyn/cm 2 ), but not high (20 dyn/cm 2 ), shear stress levels induced a pronounced increase in the mRNA expression levels of insulin growth factor-2 (IGF-2) (10-fold), vascular endothelial growth factor B (VEGF-B) and VEGF-D (3.5-fold) in human chondrosarcoma cells ( Supplementary Table S4 ). Along these lines, low fluid shear stimulated IGF-2, VEGF-B and VEGF-D secretion (Figure 2b ). As a next step, we assessed the influence of blocking antibodies specific for IGF-2, VEGF-B or VEGF-D on shear-induced MMP-12 expression and its activity. Our data reveal that the use of anti-IGF-2, anti-VEGF-B or anti-VEGF-D antibodies markedly inhibited the upregulation of MMP-12 mRNA, protein and activity levels in shear-activated SW1353 chondrosarcoma cells ( Figure 2c ). These blocking antibodies also suppressed the baseline levels of MMP-12 in static control chondrosarcoma cells (data not shown). To further establish the involvement of IGF-2, VEGF-B and VEGF-D in MMP-12 regulation, SW1353 cells were incubated with each of these growth factors for 48 h at a concentration of 100 ng/ml. As shown in Figure 2d , exogenously added IGF-2, VEGF-B or VEGF-D Figure 1 . MMP-12 expression is increased in human chondrosarcoma tissues relative to normal controls. MMP-12 immunoreactivity was determined by immunohistochemistry using an anti-MMP-12 antibody. These images are representative of six independent experiments, all revealing similar results. Lower panels show a close-up of the boxed areas. The intensity of MMP-12 immunostaining was determined using an immunohistochemical staining kit. Data represent the mean ± s.e.m. of six independent experiments. *P o0.01 with respect to normal tissue specimens.
markedly induced MMP-12 mRNA, protein and activity levels. Taken altogether, our data suggest that MMP-12 induction in response to low shear stress proceeds through the upregulation of IGF-2, VEGF-B and VEGF-D in human chondrosarcoma cells.
Shear-induced and exogenously added IGF-2, VEGF-B and VEGF-D regulate MMP-12 expression and its activity via PI3-K, p38 and JNK signaling pathways in human chondrosarcoma cells We next aimed to delineate the signaling mechanism of MMP-12 upregulation in sheared human chondrosarcoma cells. In view of our recent observations showing that shear-induced MMP-9 synthesis in human chondrocytes proceeds via PI3-K-and MAPK (ERK1/2, JNK)-dependent pathways, 20 we examined the potential contribution of these signaling pathways to MMP-12 induction in sheared chondrosarcoma cells. Exposure of SW1353 cells to a shear stress level of 2 dyn/cm 2 for 48 h augmented the phosphorylation levels of Akt at Ser 473 and p38 at Thr180/Tyr182 without affecting total Akt and p38 levels ( Figure 3a ). To establish the involvement of the PI3-K/Akt and p38 signaling pathways in shear-induced MMP-12 activation, SW1353 cells were treated with the selective PI3-K inhibitor LY294002 (10 μM) or the p38 inhibitor SB203580 (10 μM). LY294002 and SB203580 were effective in inhibiting the phosphorylation of Akt and p38, respectively, without altering their total expression levels ( Figure 3a ). They also markedly suppressed shear-induced MMP-12 mRNA, protein and activity levels (Figure 3a' ). To verify the involvement of PI3-K/Akt and p38 pathways in MMP-12 induction in sheared chondrosarcoma cells, the experiments were carried out using SW1353 cells transfected with a small interfering RNA oligonucleotide sequence specific for Akt or p38, which effectively knocked down Akt or p38 expression, respectively, relatively to cells transfected with a scramble small interfering RNA control ( Figure 3b In view of our recent observations showing the involvement of JNK and NF-κB signaling pathways in the induction of MMP-9 in chondrocytic cells, 20 we examined their potential contributions to MMP-12 regulation in human chondrosarcoma cells. Treatment of SW1353 cells with the JNK inhibitor SP600125 (10 μM) or the NF-κB inhibitor 6-amino-4-(4-phenoxyphenylethylamino) quinazoline (1 μM) nearly abolished MMP-12 expression and its activity in response to IGF-2, VEGF-B or VEGF-D stimulation (Figures 4d-f ). Collectively, our data suggest that low shear stress upregulates In contrast to low shear, high fluid shear stress fails to markedly upregulate MMP-12 expression in human chondrosarcoma cells (Figure 2a and Supplementary Tables S1). In light of prior findings showing that 15-deoxy-Δ 12,14 -prostaglandin J 2 (15d-PGJ 2 ) exerts an antagonistic effect on cytokine-mediated PI3-K-and JNKdependent NF-kB activation, 20 and given the involvement of these signaling molecules in shear-induced MMP-12 expression, we first measured 15d-PGJ 2 production in shear-activated SW1353 cells. Application of high, but not low, shear stress for 48 h markedly increased 15d-PGJ 2 secretion ( Figure 5a ). Importantly, exogenous 15d-PGJ 2 (1 μM) was sufficient to markedly inhibit MMP-12 mRNA, protein and activity levels induced by low (2 dyn/cm 2 ) shear stress (Figure 5b ). 15d-PGJ 2 exerts its effects via the peroxisome proliferator-activated receptor γ. 21 Interestingly, treatment of SW1353 cells with the peroxisome proliferator-activated receptor γ antagonist GW9662 (1 μM) before their exposure to high fluid shear for 48 h resulted in a 20-fold upregulation of MMP-12 mRNA, protein and activity levels ( Figure 5c ). Together, these data suggest the critical role of 15d-PGJ 2 in the suppression of MMP-12 expression in chondrosarcoma cells subjected to high shear.
IGF-2, VEGF-B and VEGF-D promote chondrosarcoma cell migration and invasion by activating MMP-12 via PI3-K, p38 and JNK signaling pathways A key step of chondrosarcoma cell invasion into normal tissue is the MMP-dependent degradation of the ECM. Prior work suggests that MMP-12 facilitates the invasion of glioma 11 and endometrial adenocarcinoma cells 12 though the underlying mechanisms of this process remain obscure. We thus sought to determine whether MMP-12 has the ability to regulate chondrosarcoma migration and invasion, and to delineate the underlying signaling pathways. To this end, we used a microfluidic-based migration chamber, which consists of four-walled microchannels of prescribed dimensions through which cells are induced to migrate in response to chemoattractant. [22] [23] [24] [25] [26] The cross-sectional area of the microchannels (W × H = 6 × 10 μm 2 ) was chosen to be comparable to the 8 μm pore size in typical transwell assays. Single cell motility through collagen I-coated microchannels was tracked in real time by phase contrast microscopy. In separate experiments, matrigel (3.3 mg/ml) was used instead of collagen I and was allowed to polymerize and fill up the microchannels. The invasive ability of chondrosarcoma cells to degrade the matrigel and migrate in these microchannels was monitored in real time.
Incubation of human SW1353 chondrosarcoma static control cells with shear-conditioned medium resulted in a pronounced increase of their migratory ( Figure 6a 6c and d) . To further demonstrate the critical role of MMP-12 in human chondrosarcoma cell migration and invasion, rhMMP-12 (50 ng/ml) was added to all inlets of the microchannel. Our data reveal that rhMMP-12 markedly enhanced SW1353 cell migration and invasion (Figures 7a and b) . Similar results were obtained using CH2879 chondrosarcoma cells (Supplementary Figure S1 ). Along these lines, ectopic expression of MMP-12 increases both the migratory and invasive ability of human SW1353 chondrosarcoma cells in our microchannel device (Figures 7c and d) . To further establish the role of MMP-12 in chondrosarcoma cell migration and invasion, and given that activated PI3-K, p38, JNK and NF-κB signaling pathways regulate MMP-12 expression and its activity, we evaluated the effects of selective pharmacological inhibitors on cell migration and invasion. Treatment of SW1353 cells with the PI3-K inhibitor LY294002 (10 μM) or the p38 inhibitor SB203580 (10 μM) blocked the enhancement of chondrosarcoma cell migration and invasion induced by exogenously added IGF-2, VEGF-B or VEGF-D (Figures 6c and d) . Similar observations were made using the transwell migration and invasion assays (Supplementary Figure S2 ). Along these lines, the JNK inhibitor SP600125 and the NF-κB inhibitor quinazoline also inhibited chondrosarcoma cell migration and invasion stimulated by exogenous IGF-2, VEGF-B or VEGF-D (Figures 6c and d) . Collectively, these data suggest that low levels of fluid shear (2 dyn/cm 2 ) induce IGF-2, VEGF-B and VEGF-D upregulation, which in turn augments MMP-12 expression and its activity via PI3-K-, p38-, JNK-and NF-κB-dependent pathways, thereby promoting human chondrosarcoma cell migration and invasion.
MMP-12 promotes the lung colonization in vivo
Because induction of MMP-12 promotes the migration and invasion of human chondrosarcoma cells in vitro ( Figure 6 and Supplementary Figure S1 ), we examined the potential of rhMMP-12 on forming lung tumors in a tail vein injection model. To this end, 10 5 human CH2879 chondrosarcoma cells suspended in 100 μl serum-free medium (10 6 cells/ml) were injected into immunodeficient NOD/SCID/IL2 receptor gamma knockout (NSG) mice via the tail vein followed by tail vein injections with either rhMMP-12 (10 μg/ml) or vehicle control on the day of the cell injection (t = 0 weeks) and weekly thereafter for 5 weeks. All mice (7/7) injected with vehicle control developed only mild micrometastases containing ⩽ 6 lung metastatic foci (Figure 8a) . In contrast, only 3/7 mice injected with rhMMP-12 displayed mild micrometastases, whereas 4/7 mice exhibited moderate/severe lung micrometastases (11-37 foci per section) (Figures 8a' and b) . hLINE-1 (human long interspersed nuclear element-1) analysis 27, 28 quantitatively verified the higher levels of human DNA in the lungs of mice injected with rhMMP-12 (Figure 8b' ). To further confirm these observations, mice were injected via the tail vein with CH2879 chondrosarcoma cells transfected with either MMP-12 complementary DNA or the empty vector. Ectopic expression of MMP-12 (Figure 8c ) markedly increased the lung colonization in vivo (Figures 8d and d') , as evidenced by the higher number of micrometastases ( Figure 8e ) and higher human DNA content in the lungs of mice (Figure 8e') . Collectively, these data reveal that MMP-12 enhances the lung colonization of human chondrosarcoma cells in vivo. Because low fluid shear (2 dyn/cm 2 ) induces the secretion of IGF-2, VEGF-B and VEGF-D, which are in turn is responsible for the upregulation of MMP-12 expression and its activity (Figure 2) , we evaluated the ability of sheared chondrosarcoma cells and shear-conditioned medium on the lung colonization. To this end, CH2879 cells were exposed to either static or shear (2 dyn/cm 2 ) conditions for 48 h. Next, the cells suspended in their corresponding conditioned medium were injected into mice via tail vein (t = 0 weeks); the conditioned medium was injected via the tail vein every 3 days for 5 weeks. As shown in Figures 8f-g', shear-activated chondrosarcoma cells established significantly more lung micrometastases than the static controls.
DISCUSSION
MMP-12 has divergent effects on tumor invasion and metastasis that are tumor cell type specific. For instance, MMP-12 overexpression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients 13 and with glioma and endometrial adenocarcinoma cell invasion. 11, 12 In contrast, MMP-12 expression is associated with better prognosis in colon and gastic cancer patients. 14, 29 To date, the potential role of MMP-12 in chondrosarcoma invasion and metastasis has yet to be delineated. Given that interstitial fluid flow and associated shear stress represent relevant mechanical signals in cartilage and bone (patho)physiology, 1 we also investigated the effects of fluid shear on MMP-12 regulation in human chondrosarcoma cells. In line with a prior report, showing that MMP-12 is induced in human chondrocytes during the fetal development and malignant transformation, 10 we found that MMP-12 expression is 44.5-fold higher in human chondrosarcomas than normal tissues. Low (2 dyn/cm 2 ), but not high (20 dyn/cm 2 ), fluid shear markedly (22-35fold) upregulates MMP-12 expression and its activity in all chondrosarcoma cell lines examined in this study. We further demonstrate that fluid shear induces the synthesis of IGF-2, VEGF-B and VEGF-D, which in turn transactivate MMP-12 via PI3-K-, p38-, JNK-and NF-κB-dependent signaling pathways, leading to the increased chondrosarcoma cell invasion and lung colonization (Figure 9) .
Although there is no prior direct evidence suggesting that fluid shear induces IGF-2 synthesis, others have reported that shear stress enhances VEGF expression in endothelial cells and skeletal muscles in vivo. 30, 31 VEGF has been identified to protect endothelial cells from apoptosis in response to shear stress. 30 Because high (20 dyn/cm 2 ), but not low (2 dyn/cm 2 ), fluid shear induces apoptosis in human chondrocytes, 18, 19 and given that VEGF-B and VEGF-D are only induced by low, but not high, shear stress ( Supplementary Table S4 ), we speculate that VEGF-B and VEGF-D along with IGF-2 may protect human chondrosarcoma cells from apoptosis and stimulate MMP-12 activity, thereby enhancing cell invasion and metastasis.
VEGF-B has been detected in breast carcinoma, melanoma and fibrosarcoma. 32 Moreover, VEGF-B is associated with lymph node metastasis in breast cancer. 33 Along these lines, VEGF-D promotes breast cancer metastasis via the lymphatics. 34 In addition, increased IGF-2 activity has been associated with many types of cancer. 35 In accord with these observations, we herein report that shear-induced (endogenous) or exogenous IGF-2, VEGF-B or VEGF-D potentiates the invasion of human chondrosarcoma cells by activating MMP-12, leading eventually to the increased lung colonization.
IGF-2, VEGF-B or VEGF-D augments MMP-12 expression and its activity in human chondrosarcoma cells via PI3-K-, p38-, JNK-and NF-kB-dependent signaling pathways (Figure 9 ). In line with these observations, IGF-2 has been reported to activate the PI3-K pathway during the chondrogenesis. 36 VEGF-D can also stimulate PI3-K-dependent signaling in endothelial cells. 37 VEGF has also been reported to regulate p38 activation in endothelial cells, albeit in a negative manner. 38 This difference may be attributed to the divergent responses of distinct cell types. JNK and NF-κB signaling pathways have been implicated in the regulation of MMP-9 expression in shear-activated chondrocytic cells. 20 Through the use of pharmacological inhibitors, we herein report the involvement of the JNK and NF-κB pathways in MMP-12 induction and invasion of human chondrosarcoma cells. We and others have shown that PI3-K, JNK and p38 can transactivate NF-κB. 20, 39 Because inhibition of NF-κB activity blocks IGF-2-and VEGFinduced MMP-12 synthesis, we propose that binding of phosphorylated NF-κB to its putative site(s) on the mmp-12 promoter is critical to the induction of MMP-12 expression in human chondrosarcomas. However, we cannot exclude the possibility that binding of phosphorylated c-Jun to its putative AP1 binding sites on the mmp-12 promoter might also contribute to MMP-12 expression.
The critical role of MMP-12 in growth factor-mediated chondrosarcoma cell invasion in vitro was demonstrated through the use of an anti-MMP-12 antibody or an MMP-12 inhibitor, which markedly suppressed cell invasion in a standard Transwell invasion assay and a novel three-dimensional microfluidic assay. Moreover, ectopic expression of MMP-12 was sufficient to increase the invasive ability of human chondrosarcoma cells. rhMMP-12, as well as MMP-12 overexpression enhanced the cell invasion in vitro and lung colonization in a tail vein injection model in vivo. Elevation of MMP-12 activity may potentiate chondrosarcoma cell invasion via intracellular signaling and release of ECM-bound growth factors following MMP-12-dependent ECM degradation.
Although interstitial fluid flow moves around the cell-matrix interface in all directions rather than only on the apical side, both interstitial flow and shear flow can drive cell responses via mechanical (that is, shear stress on the cell surface) and nonmechanical effects (that is, transport effects). 40 Detailed studies comparing the effects of interstitial flow versus shear flow are lacking. However, laminar shear flow experiments have been widely performed to study the mechanobiology of bone-and cartilage-derived cells. 1, 17 We postulate that interstitial fluid flow, present in the bone and the cartilage, stimulates the production of IGF-2, VEGF-B and VEGF-D in human chondrosarcoma cells, which in turn upregulates MMP-12 expression and its activity, thereby enhancing their migratory and invasive potentials in vitro and in vivo. To establish distant metastatic foci, chondrosarcoma cells need to migrate through normal three-dimensional ECMs or longitudinal channels 41 that inherently lack fluid flow or interstitial pressure. Of note, it is well established that interstitial fluid flow (IFF) is close to zero in most normal tissues. 42 Thus, our migration/invasion assays in the absence of shear flow replicate aspects of the normal tissue microenvironment.
In summary, MMP-12 is significantly upregulated in human chondrosarcoma tissues relative to normal bone controls. Of all metalloproteinases, MMP-12 is the one that exhibits the most drastic (22-35-fold) upregulation in shear-activated chondrosarcoma cells. We also delineated the signaling pathway by which MMP-12 promotes chondrosarcoma cell invasion in vitro and demonstrated the role of MMP-12 in enhancing the lung colonization/metastasis in vivo. By delineating the signaling pathway regulating MMP-12 induction, potential therapeutic targets that repress chondrosarcoma cell invasion and metastasis may be identified. The lungs were isolated 5 weeks after tail vein injection of CH2879 chondrosarcoma cells into immunodeficient NSG mice. (a and a') Mice were injected via the tail vein with either rhMMP-12 (10 μg/ml) or vehicle control at the day of the cell injection (t = 0 weeks) and weekly thereafter for 5 weeks. (d and d') In select experiments, mice were injected with CH2879 cells transfected with either MMP-12 complementary DNA or the empty vector. In separate experiments, (g and g') CH2879 cells were exposed to either static or shear (2 dyn/cm 2 ) conditions for 48 h. Cells suspended in their corresponding conditioned medium were injected into mice via tail vein (t = 0 weeks); the conditioned medium was injected via the tail vein every 3 days for 5 weeks. The right lung lobes from each animal were fixed, stained with hematoxylin and eosin and examined for signs of lung micrometastases (indicated by arrowheads). (b, e and g) Quantification of the number of micrometastases present in the lungs of mice following tail vein injection in the absence or presence of rhMMP-12 (b) or MMP-12 overexpression (e) or static-or shear-conditioned medium as described above; n = 7-10 mice per group, *Po 0.05; t-test. (b' , e' and f') Presence of human DNA quantified in the lungs of mice injected with CH2879 chondrosarcoma cells via quantitative PCR of hLINE-1 DNA. n = 7-10 mice per group, *P o0.05; t-test.
MATERIALS AND METHODS
Cell culture and shear stress exposure Human cell lines derived from chondrosarcoma grade II (SW1353 and HS 819.T obtained from American Type Culture Collection, Manassas, VA, USA) and chondrosarcoma grade III (CH2879 kindly provided by Dr Judith Bovée) were grown (37 ℃ in 5% CO 2 ) on glass slides in the appropriate medium supplemented with 10% fetal bovine serum. Before exposure to fluid shear stress, cells were incubated for 18 h in serum-free medium supplemented with 1% Nutridoma-SP (Roche Applied Science; Indianapolis, IN, USA). 18, 43, 44 Cells were subjected to shear stress for up to 48 h in medium containing 1% Nutridoma-SP using a streamer gold flow device. 19, 20 In select experiments, pharmacological agents or blocking antibodies were added to the medium at the indicated concentrations just before the onset of shear or static exposure.
Transient transfection, quantitative real-time reverse transcription PCR, western blot and casein zymography assays were performed as previously described by Zhu et al. 19 and Wang et al. 20 IGF-2, VEGF-B and VEGF-D levels in static and sheared media were measured using enzyme immunoassay kits.
Microchannel migration and invasion assays
The fabrication of the microchannel device for cell migration and invasion was previously described. [22] [23] [24] [25] [26] Microchannels of prescribed dimensions (W × H × L = 6 × 10 × 200 μm) were either pre-coated with collagen I (20 μg/ml) or filled with matrigel (3.3 mg/ml), which was allowed to polymerize at 37 ℃ for at least 1 h, before seeding chondrosarcoma cells at the cell inlet. Cells were pretreated with 100 ng/ml of IGF-2, VEGF-B, VEGF-D or vehicle controls for 1 h in the absence or presence of an anti-MMP-12 antibody (R&D Systems, Minneapolis, MN, USA), MMP-12 inhibitor (Calbiochem, La Jolla, CA, USA), the PI3-K inhibitor LY294002, the p38 inhibitor SB203580, the JNK inhibitor SP600125 or the NF-κB inhibitor quinazoline. The aforementioned growth factors, pharmacological agents or antibodies were also added to all four inlets of the migration/invasion device [22] [23] [24] [25] [26] and maintained for the entire duration of the migration or invasion assay. In select experiments, cells were pretreated with either shear-or static-conditioned media. In separate experiments, cells were treated with rhMMP-12 or vehicle control. In others, cells transfected with either MMP-12 complementary DNA or the empty vector were used in our assay. Cell migration was induced using 10% fetal bovine serum as chemotactic stimulus. To calculate the cell migration or invasion velocity, the cell center was identified as the midpoint between the poles of the cell body and was tracked by phase contrast microscopy for changes in the Y position at 20 min intervals over a 10 h period to generate an average value. Standard transwell migration and invasion assays were performed as previously described. 23 Immunohistochemistry Human bone tissue microarrays (US Biomax Inc., Rockville, MD, USA), encompassing 69 chondrosarcoma tissue cores and 24 normal bone tissue cores, were fixed with paraformaldehyde on tissue microarray slides. Slides were first deparaffinized with xylene, rehydrated in a graded series of ethanol and submerged in 3% hydrogen peroxide to eliminate endogenous peroxidase activity. MMP-12 level was determined using an immunohistochemical staining kit (Invitrogen, Carlsbad, CA, USA).
Tail vein injections
NOD/SCID/IL2 receptor gamma knockout mice (7-10 mice per experimental group; obtained from Jackson Lab, strain 005557, Bar Harbor, ME, USA) were injected via the tail vein with 10 5 CH2879 chondrosarcoma cells in a volume of 100 μl of serum-free medium followed by tail vein injection with either rhMMP-12 (100 μl of 10 μg/ml) or vehicle control at the day of the cell injection (t = 0 weeks) and weekly thereafter for 5 weeks. In select experiments, CH2879 cells transfected with MMP-12 complementary DNA or the empty vector were injected to mice via the tail vein. In separate experiments, CH2879 cells were exposed to either static or shear (2 dyn/ cm 2 ) conditions for 48 h. Next, cells suspended in their corresponding conditioned medium were injected into mice via the tail vein (t = 0 weeks); the conditioned medium was injected via the tail vein every 3 days for 5 weeks. Mice were euthanized 36 days post cell injection.
Histopathology of the lung tissue
The lung samples for pathology were fixed in 10% buffered formalin. The left lung lobe was used for hLINE analysis and the remaining lobes were for histopathological analysis of metastastatic foci. 27, 28 Tissues were collected, embedded in paraffin, sectioned at 5 μm, stained with hematoxylin and eosin and analyzed for histopathology analysis (PW and DLH, pathologists). Metastatic foci were counted in three lung histology sections from each mouse.
Quantification of hLINE-1 gene
DNA was extracted from the mouse lung tissue as previously described 27, 28 using the DNeasy blood and tissue kit (Qiagen, Valencia, CA, USA) in a sterile biological safety cabinet to minimize the risk of human DNA contamination. Elutions were analyzed via quantitative PCR as reported previously. 27, 28 Statistics Data represent the mean ± s.e.m. of at least three independent experiments. Statistical significance of differences between means was determined by Student's t-test or one-way analysis of variance, wherever appropriate. If means were shown to be significantly different, multiple comparisons by pairs were performed by the Tukey test.
